Biodesix, Inc. Common Stock BDSX
Analyst Ratings
- Consensus
- Buy — 6 Buy · 0 Hold · 0 Sell (6 analysts)
- Avg. Price Target
- $35.00 (+310.3% upside)
Key Stats
- Today's Range
- $7.96 – $13.04
- 50-Day Range
- $7.96 – $31.97
- 52-Week Range
- $5.26 – $31.97
- Volume
- 1.59 million shs
- Average Volume
- 150K shs
- Market Cap
- $209.33 million
- P/E Ratio
- —
- Dividend Yield
- —
Short Interest
- Short Interest
- 0.51%
- Days to Cover
- 1.00
About Biodesix, Inc. Common Stock
Biodesix Inc is a diagnostic solutions company with a focus on lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources: providing diagnostic testing services associated with blood-based lung and COVID tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties, as well as the development and commercialization of companion diagnostics.
Related Stocks
Compare head-to-head: BDSX vs NTRA·BDSX vs DGX·BDSX vs CAI·BDSX vs GRAL
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.